vimarsana.com

Latest Breaking News On - Corecap advisors - Page 1 : vimarsana.com

Point72 Asset Management L P Invests $112 36 Million in Immunovant, Inc (NASDAQ:IMVT)

Point72 Asset Management L.P. bought a new position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 2,666,883 shares of the company’s stock, valued at approximately $112,356,000. Other institutional investors and hedge funds also recently modified their holdings of the company. Headlands Technologies LLC acquired […]

Security National Bank Acquires Shares of 4,875 iShares Silver Trust (NYSEARCA:SLV)

Security National Bank acquired a new stake in shares of iShares Silver Trust (NYSEARCA:SLV – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 4,875 shares of the exchange traded fund’s stock, valued at approximately $106,000. A number of other hedge funds have also […]

Rhenman & Partners Asset Management AB Sells 20,000 Shares of Immunovant, Inc (NASDAQ:IMVT)

Rhenman & Partners Asset Management AB decreased its position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 12.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 146,061 shares of the company’s stock after selling 20,000 shares during the period. Rhenman & Partners Asset Management AB’s holdings in Immunovant were worth $6,154,000 at […]

Immunovant, Inc (NASDAQ:IMVT) to Post Q1 2026 Earnings of ($0 62) Per Share, HC Wainwright Forecasts

Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Stock analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for Immunovant in a note issued to investors on Thursday, May 30th. HC Wainwright analyst D. Tsao forecasts that the company will post earnings of ($0.62) per share for the quarter. HC Wainwright has […]

Constellation Brands (NYSE:STZ) PT Lowered to $288 00 at Barclays

Constellation Brands (NYSE:STZ – Free Report) had its price objective lowered by Barclays from $295.00 to $288.00 in a research report sent to investors on Wednesday morning, Benzinga reports. The brokerage currently has an overweight rating on the stock. Several other research analysts also recently weighed in on the stock. Argus upgraded shares of Constellation […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.